Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 29 June 2024.Powered by Capital Market - Live News

Concord Biotech announced that the Board of Directors of the Company at its meeting held on 23 May 2024, inter alia, have recommended the final dividend of Rs 8.75 per equity Share (i.e. 875%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Concord Biotech rose 3.86% to Rs 95.02 crore in the quarter ended March 2024 as against Rs 91.49 crore during the previous quarter ended March 2023. Sales rose 17.01% to Rs 318.97 crore in the quarter ended March 2024 as against Rs 272.59 crore during the previous quarter ended March 2023.For the full year,net profit rose 28.33% to Rs 308.10 crore in the year ended March 2024 as against Rs 240.09 crore during the previous year ended March 2023. Sales rose 19.20% to Rs 1016.94 crore in the year ended March 2024 as against Rs 853.17 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales318.97272.59 17 1016.94853.17 19 OPM %41.4146.61 -42.4440.24 - PBDT142.44137.79 3 466.16376.05 24 PBT128.72123.61 4 412.57322.01 28 NP95.0291.49 4 308.10240.09 28 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 23 May 2024Powered by Capital Market - Live News

Concord Biotech announced that Brazilian Health Regulatory Agency(ANVISA) has Issued Certificate of Good Manufacturing Practices of our Unit I (API facility) of the Company, located at Trasad Road, Dholka - 382225 in Ahmedabad, Gujarat. Powered by Capital Market - Live News